Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BY-NC-NDBMC musculoskeletal disorders

Galectin-4 is associated with inflammatory activation involving TNF-α signaling in experimental osteoarthritis.

  1. 1Department of Orthopedics, The First People's Hospital of Zhaotong, 35 Yiwei Road, Zhaoyang District, Zhaotong, Yunnan Province, 657000, China.
  2. 2Department of Orthopedics, The First People's Hospital of Zhaotong, 35 Yiwei Road, Zhaoyang District, Zhaotong, Yunnan Province, 657000, China. [email protected].

Abstract

Background

Osteoarthritis (OA) is a whole-joint degenerative disease characterized by chronic inflammation, cartilage matrix degradation, subchondral bone remodeling, pain, and progressive functional impairment. Galectin-4 (Gal-4), a member of the galectin family, has been reported to be upregulated in osteoarthritic tissues; however, its pathophysiological relevance in OA progression remains incompletely understood.Methods

A monosodium iodoacetate (MIA)-induced rat model of OA was established to investigate the association between Gal-4 and inflammatory activation in vivo. Pain-related behaviors were assessed using Lequesne MG scoring, paw withdrawal mechanical threshold (PWMT), and body weight monitoring. Histological alterations in articular cartilage were evaluated using hematoxylin and eosin staining, Safranin O/Fast Green staining, Mankin histological scoring, and immunohistochemistry. Inflammatory mediators and cartilage metabolism-related markers were analyzed using real-time quantitative PCR and enzyme-linked immunosorbent assay. To further explore the involvement of inflammatory pathways, the TNF-α inhibitor adalimumab was administered in Gal-4-treated OA rats. In addition, IL-1β-stimulated SW1353 cells were used to evaluate Gal-4-associated inflammatory and matrix-catabolic responses in vitro.Results

Gal-4 administration was associated with aggravated OA-related phenotypes, including increased pain-related behavioral abnormalities, reduced mechanical pain threshold, and more pronounced structural alterations in cartilage-containing knee joint regions. Safranin O/Fast Green staining further showed reduced and uneven Safranin O-positive cartilage matrix following Gal-4 administration, indicating impaired proteoglycan preservation. These histological changes were accompanied by increased expression of inflammatory mediators and cartilage catabolic markers, together with reduced expression of cartilage anabolic markers. Mankin scores differed significantly overall among the four experimental groups and followed the same directional pattern as the qualitative histological findings, although adjusted pairwise comparisons did not reach statistical significance. Pharmacological inhibition of TNF-α partially attenuated Gal-4-associated behavioral abnormalities, cartilage matrix alterations, and inflammatory factor expression. In vitro, Gal-4 further enhanced IL-1β-induced expression of MMP13, ADAMTS-5, TNF-α, and IL-6, reduced ACAN expression, and increased TNFR1 expression and NF-κB p65 phosphorylation in SW1353 cells. TNF-α inhibition attenuated these Gal-4-associated inflammatory and matrix-catabolic responses.Conclusion

The combined in vivo and in vitro findings suggest that Gal-4 is associated with inflammatory activation, cartilage matrix deterioration, and matrix-catabolic remodeling in experimental OA. TNF-α/NF-κB-related signaling may contribute to these Gal-4-associated inflammatory and catabolic responses. These findings support Gal-4 as a potential pathological mediator of inflammatory and cartilage-degenerative changes in OA.

Related

  1. CYBB regulates synovial fibroblast inflammatory activation and sEV-mediated synovial-cartilage communication in osteoarthritis.
    Kai Chen, Xiaoyu Dai, Peizhen Wang +6
    Arthritis research & therapyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
  2. Intraperitoneal Fetuin-A Modulates HMGB1-Associated Inflammatory Remodeling in Experimental Endometriosis
    Selim Afşar, Özgür Bulmuş, Figen Efe Çamili +10
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. EZH2 coordinates inflammatory and pain-associated pathways across joint compartments in osteoarthritis.
    Sybille Brochard, Alison Vanlaeys, Mahdia Taieb +15
    Molecular biomedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCDOAJ
  4. Network Pharmacology and Experimental Evidence Indicate That Dihydrochelerythrine from Toddalia asiatica Ameliorates Pathological Features of Knee Osteoarthritis in Rats and Is Associated with PI3K/AKT Signaling.
    Yang Liu, Yang Zhang, Qiqi Zha +4
    Journal of inflammation researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Microcystin-LR exposure induces cartilage degeneration and dysregulates osteoarthritis-associated targets: an integrative computational and experimental study
    Zhifang Tang, Zuyong Feng, Zhiyu Liang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
BibTeX
@article{zhang2026galectin4,
  title = {{Galectin-4 is associated with inflammatory activation involving TNF-α signaling in experimental osteoarthritis.}},
  author = {Zhengxue Zhang and Zhouyang Lei and Quan Wang and Wei Wen and Meifeng Li and Chunji Zhu},
  journal = {BMC musculoskeletal disorders},
  year = {2026},
  month = aug,
  doi = {10.1186/s12891-026-10237-w},
  url = {https://europepmc.org/article/MED/42958160},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Galectin-4 is associated with inflammatory activation involving TNF-α signaling in experimental osteoarthritis.
AU  - Zhengxue Zhang
AU  - Zhouyang Lei
AU  - Quan Wang
AU  - Wei Wen
AU  - Meifeng Li
AU  - Chunji Zhu
PY  - 2026
DA  - 2026/08/03
JO  - BMC musculoskeletal disorders
DO  - 10.1186/s12891-026-10237-w
UR  - https://europepmc.org/article/MED/42958160
AB  - Background  Osteoarthritis (OA) is a whole-joint degenerative disease characterized by chronic inflammation, cartilage matrix degradation, subchondral bone remodeling, pain, and progressive functional impairment. Galectin-4 (Gal-4), a member of the galectin family, has been reported to be upregulated in osteoarthritic tissues; however, its pathophysiological relevance in OA progression remains incompletely understood.Methods  A monosodium iodoacetate (MIA)-induced rat model of OA was established to investigate the association between Gal-4 and inflammatory activation in vivo. Pain-related behaviors were assessed using Lequesne MG scoring, paw withdrawal mechanical threshold (PWMT), and body weight monitoring. Histological alterations in articular cartilage were evaluated using hematoxylin and eosin staining, Safranin O/Fast Green staining, Mankin histological scoring, and immunohistochemistry. Inflammatory mediators and cartilage metabolism-related markers were analyzed using real-time quantitative PCR and enzyme-linked immunosorbent assay. To further explore the involvement of inflammatory pathways, the TNF-α inhibitor adalimumab was administered in Gal-4-treated OA rats. In addition, IL-1β-stimulated SW1353 cells were used to evaluate Gal-4-associated inflammatory and matrix-catabolic responses in vitro.Results  Gal-4 administration was associated with aggravated OA-related phenotypes, including increased pain-related behavioral abnormalities, reduced mechanical pain threshold, and more pronounced structural alterations in cartilage-containing knee joint regions. Safranin O/Fast Green staining further showed reduced and uneven Safranin O-positive cartilage matrix following Gal-4 administration, indicating impaired proteoglycan preservation. These histological changes were accompanied by increased expression of inflammatory mediators and cartilage catabolic markers, together with reduced expression of cartilage anabolic markers. Mankin scores differed significantly overall among the four experimental groups and followed the same directional pattern as the qualitative histological findings, although adjusted pairwise comparisons did not reach statistical significance. Pharmacological inhibition of TNF-α partially attenuated Gal-4-associated behavioral abnormalities, cartilage matrix alterations, and inflammatory factor expression. In vitro, Gal-4 further enhanced IL-1β-induced expression of MMP13, ADAMTS-5, TNF-α, and IL-6, reduced ACAN expression, and increased TNFR1 expression and NF-κB p65 phosphorylation in SW1353 cells. TNF-α inhibition attenuated these Gal-4-associated inflammatory and matrix-catabolic responses.Conclusion  The combined in vivo and in vitro findings suggest that Gal-4 is associated with inflammatory activation, cartilage matrix deterioration, and matrix-catabolic remodeling in experimental OA. TNF-α/NF-κB-related signaling may contribute to these Gal-4-associated inflammatory and catabolic responses. These findings support Gal-4 as a potential pathological mediator of inflammatory and cartilage-degenerative changes in OA.
SN  - 1471-2474
ER  -